Clinical Trial Update: Baricitinib, Methotrexate as Monotherapy or Combination in the Treatment of Rheumatoid Arthritis - an Open Label Randomized Clinical Trial [Phase 4]

View source ↗

Summary

An open-label randomized Phase 4 clinical trial evaluating baricitinib, methotrexate as monotherapy or in combination for rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Baricitinib (baricitinib)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Rheumatoid Arthritis | Phase 4 | Status: UNKNOWN